This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches

Read more

  • Cooperation studies on inherited susceptibility to colorectal cancer
  • Graphic



Bucharest (Romania)

September, 2021

Management Committee + Working Group 3 meeting

This meeting will focus on Tumor profiling (WG3). It will include a Management Committee meeting. Therefore, official MC members will be compulsory invited following COST regulations. This meeting is moving from March to September due to the COVID-19 situation and it could take place F2F or virtually depending on the evolution of the pandemic.

More about "Management Committee + Working Group 3 meeting"

COST is supported by the EU Framework Programme Horizon 2020